Clinical Trial Update: 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating 18F-Fluorocholine PET imaging to detect parathyroid adenomas in primary hyperparathyroidism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• 18F-Fluorocholine (fluorocholine radiotracer)

Snippet

Sponsor: Thomas Hope | Conditions: Hyperparathyroidism, Primary | Phase 3 | Status: RECRUITING